2023-09-11 06:53:28 ET
More on Crinetics
- Seeking Alpha’s Quant Rating on Crinetics Pharmaceuticals
- Historical earnings data for Crinetics Pharmaceuticals
- Financial information for Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals: Creating Next-Generation Treatments In Acromegaly
- Crinetics Pharmaceuticals: Paltusotine Phase 3 Data Presented At ENDO
- Biggest stock movers today: Tesla and Crinetics Pharmaceuticals
- Crinetics rated Outperform at Oppenheimer on upcoming Phase 3 data
For further details see:
Crinetics climbs as lead asset succeeds in Phase 3 trial for acromegaly